Table 1 Study design

From: Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results

Cohort ( n =5)

TF2 (mg)

Interval (days)

IMP288 ( μ g)

1

75

5

100

2

75

1

100

3

150

1

100

4

75

1

25

Back to article page